- This event has passed.
Virtual Workshop Addresses Development of Pediatric Treatments for COVID-19
I-ACT for Children held a virtual workshop – “Developing Pediatric Treatments for COVID-19” – to discuss the progress of (and challenges related to) developing pediatric COVID-19 treatments with regulators, biopharma developers and experts on the front lines of treating children with COVID-19. Speakers shared the latest on the clinical presentation of COVID-19 in children, the state of COVID-19 therapeutic research and innovative approaches to collecting the data required to advance safe and effective COVID-19 therapies for children.
More than 300 people participated in the workshop, which was co-moderated by I-ACT for Children Founder and Board Chair Edward Connor, MD, MBE, and Susan McCune, MD, Director of the Office of Pediatric Therapeutics at the US Food and Drug Administration.
A summary report and recommendations from the workshop have been submitted for publication consideration to a peer-reviewed journal. The workshop presentations and a recording of the meeting can be found here.